NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund

INVEST VIA NRE/NRO

HDFC Pharma and Healthcare Fund Growth for NRI [16.49]

Min Investment

100

Fund Size

1,459.59 Cr

Expense Ratio

2.2%

Exit Load

1%

SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671

16.49

0.22%

NAV as on 18 Dec 24, 12:00 AM

very high risk

sector healthcare

equity

NAV as on 18 Dec 24, 12:00 AM

very high risk

sector healthcare

equity

48.49%p.a.

Last 1Y

0.00%p.a.

Last 3Y

0.00%p.a.

Last 5Y

54.29%p.a.

Since Inception

About HDFC Pharma and Healthcare Fund Growth for NRIs

NRIs can achieve long-term capital appreciation by investing in the HDFC Pharma and Healthcare Fund Growth scheme from HDFC Asset Management Co Ltd. It is a Sector - Healthcare mutual fund scheme that predominantly invests in Sector - Healthcare stocks of companies. Launched on Oct 2023, HDFC Pharma and Healthcare Fund Growth is Sector - Healthcare fund of its category with 1,459.59 Cr fund under management as on Dec 2024. The expense ratio of this fund is less than that of most other Fund category Sector - Healthcare funds.

  • HDFC Pharma and Healthcare Fund Growth delivered 48.5% annual returns during the last year. It has delivered 54.3% average annual returns since the fund was launched.
  • HDFC Pharma and Healthcare Fund Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
  • The scheme has predominantly invested in equity

Fund Objective

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.

Top 10 Holdings

Sun Pharmaceuticals Industries Ltd

13.48%

Divi's Laboratories Ltd

7.85%

Cipla Ltd

7.75%

Lupin Ltd

5.80%

Gland Pharma Ltd

3.99%

Ipca Laboratories Ltd

3.75%

Aster DM Healthcare Ltd Ordinary Shares

3.57%

Vijaya Diagnostic Centre Ltd

3.54%

Eris Lifesciences Ltd Registered Shs

3.38%

Glenmark Pharmaceuticals Ltd

3.37%

Fund Managers

  1. Dhruv Muchhal (Oct 2023 - Present)
  2. Nikhil Mathur (Oct 2023 - Present)

Key Information

View Scheme Document

HDFC Pharma and Healthcare Fund Growth SIP Calculator

If invested

5,000

per month

For a period of

Investment of 0 could have been

0(+0.0%)

0 (+0.0%)

This Fund

0 (+0.0%)

Fixed Deposit

NRI Mutual Fund Tax on HDFC Pharma and Healthcare Fund Growth

Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.

Fund TypeShort-term Capital Gains (STCG) TaxLong-term Capital Gains (LTCG) Tax
Equity mutual funds15%10% (above Rs. 1 lakh LTCG) without indexation*
Debt & other types of fundsAt tax slab rate20% with indexation benefits

How can NRIs invest in HDFC Pharma and Healthcare Fund Growth?

NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:

  • Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
  • PAN Number
  • Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
  • Passport – front and back
  • Passport size photograph
  • signature

If all details are correct, your KYC will be approved within 7 to 8 business days.

  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in HDFC Pharma and Healthcare Fund Growth
  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
  • City and country of birth
  • NRE/NRO bank account statement/ canceled cheque for the latest 3 months
  • Nominee details

Frequently Asked Questions